2-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine dihydrochloride, 95.0%, 5g

1,1,3,3,5,5,7,7,9,9,11,11-Dodecamethylhexasiloxane>96.0%(GC)5mL

(2r,4s)-1-[(tert-butoxy)carbonyl]-4-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)pyrrolidine-2-carboxylic acid, 97%, 1g

1-(5-Fluoro-2-methyl-3-nitrophenyl)ethanone, 98+%, 250mg

Heptadecanedioic acid, 98.0%, 5g

1,3,5-Tris[4-(diphenylamino)phenyl]benzene>95.0%(N)200mg

1-Boc-3-Hydroxymethylindole, 95.0%, 25g

3-Bromo-4-fluoro-N-methyl-benzenesulfonamide, 95%+, 10g

(S)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide, 95.0%, 10g

4-(4-Aminomethyl-piperidin-1-ylmethyl)-benzonitrile hydrochloride, 95.0%, 1g

2-(4-Iodophenoxy)acetic acid, 95.0%, 500g

5-Hydroxy-2-methyl-piperidine-1-carboxylic acid benzyl ester, 98+%, 2g

Acide L(+)-ascorbique, min 99 %, pa, 100 g, emballage plastique.